Lilly’s oral GLP-1, orforglipron, showed compelling efficacy and a safety profile consistent with injectable GLP-1 medicines, in complete Phase 3 results published in The New England Journal of Medicine
Share Facebook Twitter LinkedIn Pinterest Email Tim Ream spoke on what it means to play for the United States in the Gold Cup and Jenny Taft gave updates on the USMNT.
